Lars Henrik Jensen

Denmark

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (6)

Annette Raskov Kodahl

Odense University Hospital

DENMARK

View details

Birgitte Nørgaard

University of Southern Denmark

DENMARK

View details

Bonna Leerhøy

Head of Clinical Research, PhD

Copenhagen University Hospital

DENMARK

View details

Morten Ladekarl

Aalborg University

DENMARK

View details

Silvia Regina Rogatto

DENMARK

View details

Julie Gehl

Zealand University Hospital

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lars Henrik Jensen

Research Interests

Contact this professor

Articles (11)

ProTarget

Delta tocotrienol as a supplement to FOLFOXIRI in first-line treatment of metastatic colorectal cancer. A randomized, double-blind, placebo-controlled phase II study

Calcium electroporation in cutaneous metastases – A non-randomised phase II multicentre clinical trial

Open dialogue about complementary and alternative medicine early in the oncology treatment trajectory

Delta tocotrienol as a supplement to FOLFOXIRI in first-line treatment of metastatic colorectal cancer. A randomized, double-blind, placebo-controlled phase II study

Precision medicine applied to metastatic colorectal cancer using tumor-derived organoids and in-vitro sensitivity testing: a phase 2, single-center, open-label, and non-comparative study

Development and validation of circulating protein signatures as diagnostic biomarkers for biliary tract cancer

ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling - a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial

Protein Signatures and Individual Circulating Proteins, including IL-6 and IL-15, Associated with Prognosis in Patients with Biliary Tract Cancer

Protein Signatures and Individual Circulating Proteins, including IL-6 and IL-15, Associated with Prognosis in Patients with Biliary Tract Cancer

Open dialogue about complementary and alternative medicine early in the oncology treatment trajectory. A qualitative study of patients' lived experiences

Collaborators (6)

Annette Raskov Kodahl

Birgitte Nørgaard

Bonna Leerhøy

Morten Ladekarl

Silvia Regina Rogatto

Julie Gehl

Make your next move.